with Recovery clinic · Recovery clinic
LenderHawk analysis. Not affiliated with or endorsed by Acquisitions Anonymous.
A treatment center’s true quality is often better judged by relapse or retention outcomes than by headline EBITDA.
Out-of-network insurance can still mean a high-end patient base, but it also requires careful diligence on how much the patient actually pays versus the insurer.
Revenue per patient only matters if the business can keep patients through a long enough care cycle to capture that value.
A business in addiction treatment can look financially attractive while still being hard to finance because lenders may apply a stigma discount.
Multiple levels of care can support longer patient engagement and higher lifetime revenue if the program is designed to move patients through the continuum.
Heavy real-estate and payroll needs make working capital and facility structure important diligence items in treatment businesses.
Specialized niches such as sports therapy, equine therapy, or veteran access can differentiate a rehab center and support premium positioning.
The business is stronger when it can move a patient through multiple care levels, from outpatient to more intensive programs, rather than relying on a single service line.
When to use: Use this lens when evaluating addiction-treatment providers or other healthcare businesses with layered service offerings.
The listing showed $3.5 million of revenue and $1.1 million of EBITDA in 2022, then $5.2 million of revenue and $2.1 million of EBITDA in 2023.
The hosts used the two-year financials to assess growth and margin expansion.
The 2023 EBITDA margin was about 40%.
The hosts highlighted the unusually high profitability for a staffed healthcare operation.
The business claims about $100,000 of revenue per patient.
That figure became a key anchor for discussing patient length of stay and economics.
About 75% of patients use insurance and about 25% are self-pay.
The hosts treated payer mix as central to understanding the clientele and cash flow.
The clinic says it has recently secured access to military and veteran communities.
This was cited as a source of incremental patient demand.
The services include PHP, IOP, and OP levels of care plus dual-diagnosis options.
The hosts unpacked the treatment stack to infer how patients move through the program.
The business is in the U.S. mountain region and has multiple sober living houses near the office.
Geography and facility structure were discussed as part of the operating model.
Check relapse and retention metrics before buying a treatment center.
Why: Those outcome measures are closer to real quality than EBITDA alone and help screen for unethical or low-quality operations.
Verify how much of the billed amount is actually collected from patients versus insurers.
Why: An out-of-network insurance model can make a business look premium while still pushing significant cost to patients.
Diligence the exact mix of PHP, IOP, OP, residential, and sober-living capacity.
Why: The service mix determines how long patients stay, how revenue per head is generated, and how staffing and facilities need to be structured.
Treat working capital, payroll, and real estate as core diligence items.
Why: These businesses are labor-heavy and facility-heavy, so margin quality depends on operational discipline.
Look for a defensible niche such as athlete-focused care or veteran access.
Why: Specialization can support pricing power and improve patient fit in a crowded rehab market.
The hosts used Passages Malibu as an example of a luxury rehab brand that markets heavily, sits in an affluent location, and targets high-end families willing to pay privately.
Lesson: High-end rehab businesses often win by branding, niche positioning, and affluent geography rather than by broad insurance dependence.
Mills and Heather referenced a prior deal in remote Utah to illustrate how being far from a patient’s home can be either a feature or a bug depending on the family and treatment model.
Lesson: Distance from home can support treatment goals, but it also narrows the buyer pool and changes patient willingness to enroll.